Results 121 to 130 of about 109,871 (361)

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group. [PDF]

open access: yes, 2017
Cancer immunotherapy has transformed the treatment of cancer. However, increasing use of immune-based therapies, including the widely used class of agents known as immune checkpoint inhibitors, has exposed a discrete group of immune-related adverse ...
Abdallah, K.   +80 more
core   +2 more sources

Anaplastic Thyroid Carcinoma Histologically Mimicking a Plasmacytoma. [PDF]

open access: yes, 2020
Anaplastic (undifferentiated) thyroid carcinoma (ATC) is a rare malignancy which may arise from transformation of a pre-existing differentiated carcinoma. We report the unique case where a lesion of thyroid origin presented with the histological features
Mo, Joshua H   +4 more
core   +1 more source

Patients With Antithyroid Antibodies Are Prone To Develop Destructive Thyroiditis by Nivolumab: A Prospective Study

open access: yesJournal of the Endocrine Society, 2018
Context Immune checkpoint inhibitors, including anti–programmed cell death-1 (PD-1) antibodies, have become promising treatments for a variety of advanced malignancies.
Tomoko Kobayashi   +23 more
semanticscholar   +1 more source

Lymphocytic Thyroiditis

open access: yesDefinitions, 2020
An inflammatory disorder that affects the thyroid gland. It is characterized by the infiltration of the thyroid parenchyma by lymphocytes. It includes Hashimoto thyroiditis and subacute lymphocytic thyroiditis.

semanticscholar   +1 more source

Cytological Alterations of Benign Thyroid Nodules Following Radiofrequency Ablation

open access: yesThe Laryngoscope, EarlyView.
This prospective study of 312 patients with benign thyroid nodules treated with radiofrequency ablation showed a 3.84% progression to Bethesda III cytology, all confirmed benign by molecular testing, with an 88% volume reduction at 60 months and no major complications.
Emad Kandil   +6 more
wiley   +1 more source

CEREBRAL CAVERNOUS MALFORMATION COEXISTING WITH PITUITARY ADENOMA, HASHIMOTO THYROIDITIS AND MENTAL ILLNESS: FIRST CASE REPORT.

open access: yesEuromediterranean Biomedical Journal, 2017
Cerebral Cavernous Malformations (CCMs) are vascular lesions involving brain capillaries. They may occur sporadically or be inherited as autosomal dominant character.
Sara Guido
doaj   +1 more source

Transient hypercortisolism and symptomatic hyperthyroidism associated to primary hyperparathyroidism in an elderly patient: case report and literature review. [PDF]

open access: yes, 2015
Background: Primary hyperparathyroidism (PHPT) is often found on routine blood tests, at a relatively asymptomatic stage. However many studies suggest different systemic effects related to PHPT, which could be enhanced by an abnormal cortisol release due
Armanini, Decio   +6 more
core   +2 more sources

A Case of Post-COVID-19 Subacute Thyroiditis

open access: yesCureus, 2020
Subacute thyroiditis is usually a self-limiting inflammatory condition. The clinical presentation varies from person to person, but usually includes neck pain or discomfort and a painful diffuse goiter.
Maham Mehmood, M. Bapna, Mahnoor Arshad
semanticscholar   +1 more source

Optimized Dynamic Network Biomarker Deciphers a High‐Resolution Heterogeneity Within Thyroid Cancer Molecular Subtypes

open access: yesMed Research, EarlyView.
An optimized dynamic network biomarker approach reveals a critical transition signal and identifies three distinct molecular subtypes of differentiated thyroid cancer, each with unique global regulatory landscapes. ABSTRACT The progression of differentiated thyroid carcinoma (DTC) poses significant clinical challenges, especially in determining the ...
Haonan Zhang   +20 more
wiley   +1 more source

Mechanism-based strategies for the management of autoimmunity and immune dysregulation in primary immunodeficiencies [PDF]

open access: yes, 2016
A broad spectrum of autoimmunity is now well described in patients with primary immunodeficiencies (PIDs). Management of autoimmune disease in the background of PID is particularly challenging given the seemingly discordant goals of immune support and ...
Cooper, Megan A   +4 more
core   +2 more sources

Home - About - Disclaimer - Privacy